IMcoMET is a MedTech startup. We have developed a technology, called the M-Duo Technology®, that allows access and control of fluid around cells, called interstitial fluid. This fluid contains many biomarkers that provide detailed information about both the local tissue condition and general health status of an individual. We are integrating our M-Duo Technology® into a set of tools to improve skin diagnostics and research to drive personalized medicine and biomedical research forward. Both with the ultimate goal to improve therapy outcomes for patients with inflammatory skin diseases.
| Website | https://imcomet.com/ |
| Employees | 5 (3 on RocketReach) |
| Founded | 2018 |
| Phone | +31 10 704 4843 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Research Services |
| Keywords | Medtech, Biomarker Discovery, Biomarker Detection, Cell Analysis, Diagnostic Technology, Precision Medicine, Diagnostic Tools, Medical Technology, Fluid Management, In-Vitro Diagnostics, Medical Devices, Health Technology, Lab Technology, Biotechnology, Therapeutic Technology, Life Sciences, Healthcare Technology |
Looking for a particular IMcoMET employee's phone or email?
Martin Bakker is the Director of Business Development of IMcoMET.
3 people are employed at IMcoMET.